Amdocs Statistics
Total Valuation
Amdocs has a market cap or net worth of $8.48 billion. The enterprise value is $8.98 billion.
Important Dates
The last earnings date was Tuesday, November 11, 2025, after market close.
| Earnings Date | Nov 11, 2025 |
| Ex-Dividend Date | Dec 31, 2025 |
Share Statistics
Amdocs has 109.99 million shares outstanding. The number of shares has decreased by -3.79% in one year.
| Current Share Class | 109.99M |
| Shares Outstanding | 109.99M |
| Shares Change (YoY) | -3.79% |
| Shares Change (QoQ) | +0.69% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 100.09% |
| Float | 107.73M |
Valuation Ratios
The trailing PE ratio is 15.26 and the forward PE ratio is 10.35. Amdocs's PEG ratio is 1.16.
| PE Ratio | 15.26 |
| Forward PE | 10.35 |
| PS Ratio | 1.89 |
| Forward PS | 1.79 |
| PB Ratio | 2.46 |
| P/TBV Ratio | 22.16 |
| P/FCF Ratio | 13.14 |
| P/OCF Ratio | 11.32 |
| PEG Ratio | 1.16 |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 9.01, with an EV/FCF ratio of 13.92.
| EV / Earnings | 15.90 |
| EV / Sales | 1.98 |
| EV / EBITDA | 9.01 |
| EV / EBIT | 11.21 |
| EV / FCF | 13.92 |
Financial Position
The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.24.
| Current Ratio | 1.17 |
| Quick Ratio | 0.93 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | 0.79 |
| Debt / FCF | 1.28 |
| Interest Coverage | 25.93 |
Financial Efficiency
Return on equity (ROE) is 16.29% and return on invested capital (ROIC) is 11.66%.
| Return on Equity (ROE) | 16.29% |
| Return on Assets (ROA) | 7.92% |
| Return on Invested Capital (ROIC) | 11.66% |
| Return on Capital Employed (ROCE) | 16.38% |
| Revenue Per Employee | $155,995 |
| Profits Per Employee | $19,434 |
| Employee Count | 29,058 |
| Asset Turnover | 0.72 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Amdocs has paid $125.47 million in taxes.
| Income Tax | 125.47M |
| Effective Tax Rate | 18.10% |
Stock Price Statistics
The stock price has decreased by -11.74% in the last 52 weeks. The beta is 0.43, so Amdocs's price volatility has been lower than the market average.
| Beta (5Y) | 0.43 |
| 52-Week Price Change | -11.74% |
| 50-Day Moving Average | 80.70 |
| 200-Day Moving Average | 86.40 |
| Relative Strength Index (RSI) | 44.69 |
| Average Volume (20 Days) | 1,469,146 |
Short Selling Information
| Short Interest | 4.76M |
| Short Previous Month | 5.09M |
| Short % of Shares Out | 5.32% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 4.49 |
Income Statement
In the last 12 months, Amdocs had revenue of $4.53 billion and earned $564.70 million in profits. Earnings per share was $5.05.
| Revenue | 4.53B |
| Gross Profit | 1.72B |
| Operating Income | 801.04M |
| Pretax Income | 693.24M |
| Net Income | 564.70M |
| EBITDA | 996.48M |
| EBIT | 801.04M |
| Earnings Per Share (EPS) | $5.05 |
Full Income Statement Balance Sheet
The company has $325.00 million in cash and $826.40 million in debt, giving a net cash position of -$501.40 million or -$4.56 per share.
| Cash & Cash Equivalents | 325.00M |
| Total Debt | 826.40M |
| Net Cash | -501.40M |
| Net Cash Per Share | -$4.56 |
| Equity (Book Value) | 3.47B |
| Book Value Per Share | 31.38 |
| Working Capital | 233.35M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $749.10 million and capital expenditures -$103.95 million, giving a free cash flow of $645.14 million.
| Operating Cash Flow | 749.10M |
| Capital Expenditures | -103.95M |
| Free Cash Flow | 645.14M |
| FCF Per Share | $5.87 |
Full Cash Flow Statement Margins
Gross margin is 38.00%, with operating and profit margins of 17.67% and 12.46%.
| Gross Margin | 38.00% |
| Operating Margin | 17.67% |
| Pretax Margin | 15.29% |
| Profit Margin | 12.46% |
| EBITDA Margin | 21.98% |
| EBIT Margin | 17.67% |
| FCF Margin | 14.23% |